Antibody microarray analysis of signaling networks regulated by Cxcl13 and Cxcr5 in prostate cancer

Journal of Proteomics and Bioinformatics

Volumn 5, Issue 8, 2012, Pages 177-184

  El Haibi, Christelle P ^a   Singh, Rajesh ^b   Gupta, Pranav ^b   Sharma, Praveen K ^c   Greenleaf, Krysta N ^b   Singh, Shailesh ^b   Lillard Jr , James W ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c CENTRAL UNIVERSITY OF JHARKHAND   (India)

Author keywords

Akt; Cdk; CDKN1B; Fak; Integrin 3; Paxillin; Src

Indexed keywords

AKT 1 PROTEIN; BETA3 INTEGRIN; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FOCAL ADHESION KINASE; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN KINASE B BETA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER LOCALIZATION; CELL CYCLE; CELL GROWTH; CELL INVASION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; INTRACELLULAR SIGNALING; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; UNINDEXED SEQUENCE;

EID: 84866089787     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.1000232     Document Type: Article

References (44)

1. Eder IE, Bektic J, Haag P, Bartsch G, Klocker H (2004) Genes differentially expressed in prostate cancer. BJU Int 93: 1151-1155.
2. Sadar MD, Hussain M, Bruchovsky N (1999) Prostate cancer: molecular biology of early progression to androgen independence. Endocr Relat Cancer 6: 487-502.
3. Zhou J, Scholes J, Hsieh JT (2001) Signal transduction targets in androgen-independent prostate cancer. Cancer Metastasis Rev 20: 351-362.
4. Hanahan D, Weinberg RA (2000) The hallmark of cancer. Cell 100: 57-70.
5. Gioeli D (2005) Signal transduction in prostate cancer progression. Clin Sci 108: 293-308.
6. Walczak JR, Carducci MA (2007) Prostate Cancer: A Practical Approach to Current Management of Recurrent Disease. Mayo Clin Proc 82: 243-249.
7. Msaouel P, Pissimissis N, Halapas A, Koutsilieris M (2008) Mechanisms of bone metastasis in prostate cancer: clinical implications. Best Pract Res Clin Endocrinol Metab 22: 341-355.
8. Klocker H, Culig Z, Kaspar F, Hobisch A, Eberle J, et al. (1994) Androgen signal transduction and prostatic carcinoma. World J Urol 12: 99-103.
9. Maitland NJ, Macintosh CA, Hall J, Sharrard M, Quinn J, et al. (2001) In vitro models to study cellular differentiation and function in human prostate cancers. Radiat Res 155: 133-142.
10. Mitchell S, Abel P, Ware M, Stamp G, Lalani E (2000) Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU Int 85: 932-944.
11. Edwards J, Bartlett JM (2005) The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways. BJU Int 95: 1327-1335.
12. Kakinuma T, Hwang ST (2006) Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79: 639-651.
13. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I (2007) Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 98: 1652-1658.
14. Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, et al. (2005) Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Endocr Relat Cancer 12: 119-134.
15. Singh S, Singh R, Singh UP, Rai SN, Novakovic KR, et al. (2009) Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and prostate cancer cell lines. Int J Cancer 125: 2288-2295.
16. Singh S, Singh R, Sharma PK, Singh UP, Rai SN, et al. (2009) Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett 283: 29-35.
17. Zong Y, Zhang S, Chen HT, Zong Y, Shi Y (2007) Forward-phase and reverse-phase protein microarray. Methods Mol Biol 381: 363-374.
18. John P, Mews M, Moore R (2001) Cyclin/cdk complexes: Their involvement in cell cycle progression and mitotic division. Protoplasma 216: 119-142.
19. Ivanchuk SM, Rutka JT (2004) The Cell Cycle: Accelerators, Brakes, and Checkpoints. Neurosurgery 54: 692-699.
20. Donnellan R, Chetty R (1999) Cyclin E in human cancers. FASEB J 13: 773-780.
21. Zhang W, Bergamaschi D, Jin B, Lu X (2005) Post-translational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo. Blood 105: 3691-3698.
22. Manes T, Zheng DQ, Tognin S, Woodard AS, Marchisio PC, et al. (2003) Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration. J Cell Biol 161: 817-826.
23. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, et al. (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6: 154-161.
24. Shen TL, Guan JL (2001) Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett 499: 176-181.
25. Oktay M, Wary KK, Dans M, Birge RB, Giancotti FG (1999) Integrin-mediated Activation of Focal Adhesion Kinase is Required for Signaling to Jun NH2-terminal Kinase and Progression through the G1 Phase of the Cell Cycle. J Cell Biol 145: 1461-1469.
26. Weston CR, Davis RJ (2002) The JNK signal transduction pathway. Curr Opin Genet Dev 12: 14-21.
27. Fang J, Ding M, Yang L, Liu LZ, Jiang BH (2007) PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal 19: 2487-2497.
28. Cooney KA, Tsou HC, Petty EM, Miesfeldt S, Ping XL, et al. (1999) Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer. Clin Cancer Res 5: 1387-1391.
29. Ghosh PM, Malik S, Bedolla R, Kreisberg JI (2003) Akt in prostate cancer: possible role in androgen-independence. Curr Drug Metab 4: 487-496.
30. Blanco-Aparicio C, Renner O, Leal JFM, Carnero A (2007) PTEN, more than the AKT pathway. Carcinogenesis 28: 1379-1386.
31. Vivanco I, Palaskas N, Tran C, Finn SP, Getz G, et al. (2007) Identification of the JNK Signaling Pathway as a Functional Target of the Tumor Suppressor PTEN. Cancer Cell 11: 555-569.
32. Husson H, Freedman AS, Cardoso AA, Schultze J, Munoz O, et al. (2002) CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells. Br J Haematol 119: 492-495.
33. Garrison JB, Kyprianou N (2004) Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy. Curr Cancer Drug Targets 4: 85-95.
34. Rennebeck G, Martelli M, Kyprianou N (2005) Anoikis and Survival Connections in the Tumor Microenvironment: Is There a Role in Prostate Cancer Metastasis? Cancer Res 65: 11230-11235.
35. Ruvolo PP, Deng X, May WS (2001) Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15: 515-522.
36. Tang DG, Porter AT (1997) Target to apoptosis: A hopeful weapon for prostate cancer. The Prostate 32: 284-293.
37. Kung HJ (2011) Targeting tyrosine kinases and autophagy in prostate cancer. Horm Cancer 2: 38-46.
38. Wegiel B, Bjartell A, Culig Z, Persson JL (2008) Interleukin-6 activates PI3K/ Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer 122: 1521-1529.
39. Yu W, Feng S, Dakhova O, Creighton CJ, Cai Y, et al. (2011) FGFR-4 Arg388 enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling. Clin Cancer Res 17: 4355-4366.
40. Xiao LJ, Lin P, Lin F, Liu X, Qin W, et al. (2012) ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol 40: 1714-1724.
41. Wilson DS, Nock S (2003) Recent Developments in Protein Microarray Technology. Angew Chem Int Ed Engl 42: 494-500.
42. Cohen P (2000) The regulation of protein function by multisite phosphorylation -a 25 year update. Trends Biochem Sci 25: 596-601.
43. Krupa A, Srinivasan N (2002) The repertoire of protein kinases encoded in the draft version of the human genome: atypical variations and uncommon domain combinations. Genome Biol 3: research0066.
44. Ptacek J, Snyder M (2006) Charging it up: global analysis of protein phosphorylation. Trends Genet 22: 545-554.